Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT. Nitrasanata Dharma Tbk.
JECX
Sector: -
Industry: -
Sub Sector: -
Sub Industry: -
Live quote
tidak tersedia
Highlight Keuangan (2025 Q4) (In Rp)
EPS
25
ROE
11,06%
ROA
5,08%
Book Value
228
Net Income
73,76 M
Total Sales
926,76 M
Total Assets
1,45 T
DER
0.96x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
16,49%
SARANA MEDITAMA METROPOLITAN TBK PT 🔗
28,63%
Corporate · Lokal
DR DARWAN MADJA PURBA 🔗
11,79%
Individual · Lokal
MAGNA SELARAS LESTARI PT 🔗
9,13%
Corporate · Lokal
NABILL WARDHANA ISTIANTORO 🔗
8,90%
Individual · Lokal
RAYYAN FARREL WARDHANA ISTIANTORO 🔗
8,90%
Individual · Lokal
ALPHAGATE CAPITAL II LP 🔗
3,81%
Mutual Funds · Asing
WIDYA ARTINI WIYOGO 🔗
3,33%
Individual · Lokal
DRGRIFI ARANTI 🔗
2,70%
Individual · Lokal
DR.HADISUDJONO.S. SP M 🔗
1,61%
Individual · Lokal
UBS AG HONGKONG 🔗
1,39%
Private Bank · Asing
DR DARMAYANTI SISWOYO 🔗
1,16%
Individual · Lokal
DR TJAHJONO D G 🔗
1,08%
Individual · Lokal
DR. DR. VIDYAPATI W. MANGUNKUSUMO, SPM 🔗
1,08%
· Lokal
Tentang Perusahaan
PT Nitrasanata Dharma Tbk (the Company) was established based on Notarial Deed No. 526 of Richardus Nangkih Sinulingga, S.H., dated November 28, 1990. The Company started its commercial operations in 1990. PT Magna Selaras Lestari is the controlling entity of the Company, and Dr. Darwan Madja Purba, SpM(K) as ultimate beneficial owner of the Company.
Produk & Lini Bisnis
The Company is engaged in the eye healthcare servicesPT. Sarana
Dewan Direksi
DD
DR. Dr. Johan A.M.M. Hutauruk, Sp.M(K)
President Director
PD
Prof. Dr. Tjahjono D. Gondhowiardjo, Sp.M(K)., Ph.D.
Director
TP
Titin Prihatiningsih, S.E., MARS., CMA.
Director
BD
Budi Djatmiko, BBA
Director
NA
Ngo Adrian
Director
Dewan Komisaris
DD
Dr. Darwan Madja Purba, Sp.M(K)
President Commissioner
DA
Dr. Admar Anwar, Sp.An-TI.Subsp. TI(K)
Commissioner
AH
Agus Hermawan Istiantoro, B.S.B.A., MBA
Commissioner
JH
Jusup Halimi, MBA
Commissioner
YP
Yustina Peniyanti Jap
Independent Commissioner
HS
Heri Sunaryadi
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
PT. Sapta Grha Binanetra
Building rental
 Jakarta 51.00%
PT. JEC Medika Indonesia
Eye clinic
 Jakarta 99.99%
PT. Soca Paravan Mukti Husada
Eye clinic
 Pasuruan 20.00%
PT. Nitrasanata Bali
Eye clinic
 Bali 99.99%
PT. Dadaha Mukti Husada
Eye clinic
 Kediri 20.00%
PT. JEC Orbita Kendari
Eye clinic
 Kendari 20.00%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
927jt 695jt 463jt 232jt 0 Sales 2023Q4: Rp 825.085.000 Net Income 2023Q4: Rp 114.075.000 2023Q4 Sales 2024Q4: Rp 887.715.000 Net Income 2024Q4: Rp 65.010.000 2024Q4 Sales 2025Q4: Rp 926.763.000 Net Income 2025Q4: Rp 73.760.000 2025Q4
2023 Q4
EPS 39
ROE 16,88%
2024 Q4
EPS 22
ROE 9,86%
2025 Q4
EPS 25
ROE 11,06%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2025 Q4 926,76 M 73,76 M 1,45 T 666,64 M 25 11,06% 0.96x
2024 Q4 887,72 M 65,01 M 1,42 T 659,35 M 22 9,86% 0.93x
2023 Q4 825,09 M 114,08 M 1,35 T 675,61 M 39 16,88% 0.77x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
231 230 228 227 225 Book Value 2023Q4: Rp 231 2023Q4 Book Value 2024Q4: Rp 225 2024Q4 Book Value 2025Q4: Rp 228 2025Q4
2023 Q4
Close -
BV 231
ROA 8,43%
2024 Q4
Close -
BV 225
ROA 4,57%
2025 Q4
Close -
BV 228
ROA 5,08%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2025 4 - 228 5,08%
2024 4 - 225 4,57%
2023 4 - 231 8,43%
Data diperbarui pada: 2026-08-11 08:26:00